本页面由Tiger Trade Technology Pte. Ltd.提供服务

Unicycive Therapeutics, Inc.

6.68
+0.06000.91%
盘后6.850.1700+2.54%19:46 EDT
成交量:95.63万
成交额:615.49万
市值:1.69亿
市盈率:-4.00
高:6.70
开:6.57
低:6.26
收:6.62
52周最高:11.00
52周最低:3.71
股本:2,523.78万
流通股本:2,164.57万
量比:1.34
换手率:4.42%
股息:- -
股息率:- -
每股收益(TTM):-1.6715
每股收益(LYR):-5.6466
净资产收益率:-141.14%
总资产收益率:-45.66%
市净率:5.58
市盈率(LYR):-1.18

数据加载中...

2025/04/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/01

重要事件披露

Form 8-K - Current report
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/19

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/25

重要事件披露

Form 8-K - Current report
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/19

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/15

重要事件披露

Form 8-K - Current report